Evidence of Clinical Inertia in Management of T2DM

TUESDAY, July 17, 2018 -- Many patients with type 2 diabetes (T2D) who have a hemoglobin A1c (HbA1c) level expected to trigger treatment intensification often have treatment inappropriately delayed, according to a research letter published in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news